CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $32,396 | +8.7% | 28,669 | 0.0% | 0.00% | – |
Q1 2023 | $29,816 | -20.0% | 28,669 | -13.8% | 0.00% | – |
Q4 2022 | $37,258 | -17.2% | 33,266 | -15.6% | 0.00% | – |
Q3 2022 | $45,000 | -8.2% | 39,438 | +17.9% | 0.00% | – |
Q2 2022 | $49,000 | +81.5% | 33,448 | +184.5% | 0.00% | – |
Q1 2022 | $27,000 | – | 11,757 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |